Abstract Details

Title Methylphenidate's Effects on Cognition in Patients with Epilepsy: A Randomized, Double-Blind, Placebo-Controlled, Crossover, Single-Dose Study

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) (-)

Poster/Presentation
Number 002

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
	No disclosure on file
Katherine S. Inoyama, MD (Neurology Group of Bergen County)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
John J. Barry, MD (Stanford Univ School of Medicine,)	No disclosure on file
David W. Loring, PhD, FAAN (Emory Univ, Dept of Neurology)	Dr. Loring has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. Dr. Loring has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE. The institution of Dr. Loring has received research support from NIH. Dr. Loring has received publishing royalties from a publication relating to health care.
Kimford J. Meador, MD, FAAN (Stanford University School of Medicine)	The institution of Dr. Meador has received research support from NIH. The institution of Dr. Meador has received research support from Eisai. The institution of Dr. Meador has received research support from Medtronics. The institution of Dr. Meador has received research support from The Epilepsy Consortium.

��ɫ��